In summary, incretin receptor agonists demonstrate consistent anti-fibrotic effects in vivo , reducing hepatic stellate cell activation, oxidative stress, and collagen deposition in animal models, and improving fibrosis outcomes in clinical MASLD and MASH studies
However, things get more complicated when it comes to getting Medicare to cover Wegovy for weight loss
In a second study, multiple procedures (median 3, range 2-18) of hydrodistension (80 cm H 2 O for 2 min) did not decrease bladder capacity in patients with IC/BPS (initial and final bladder capacities: 730 cc versus 750 cc
The logic: if they can help people stay on effective medications, they reduce long-term risk
If mood symptoms are significant or persistent, don't hesitate to ask for a referral to a behavioral health specialist